Global Ventricular Assist Device (VAD) Market Sales Industry Research Report 2022

Infinium Global Research has added a new report on Global Ventricular Assist Device (VAD) Market. The report predicts the market size of Ventricular Assist Device (VAD) is expected to reach XX billion by 2022

A VAD or Ventricular Assist Device is an electromechanical pump that is implanted inside a person’s chest for assisting cardiac circulation, which is used to either to partially or to completely replace the function of a weakened heart. A VAD is dissimilar from an artificial cardiac pacemakers. An artificial cardiac pacemaker replaces the weak heart permanently, whereas a VAD works with the heart to help it pump more blood with less work. It does this by continuously taking blood from the ventricle and moving it to the aorta, which then delivers oxygen-rich blood throughout the body. Some of the VADs are used for short term, typically for patients recovering from myocardial infarction and for patients recovering from heart surgery; and some are used for long-term, which includes for patients suffering from advanced congestive heart failure. Moreover. These VADs are designed to assist either right ventricle or the left ventricle or to assist both ventricles. Among these, LVAD implantations are huge in number and accounted for highest market share due to a high number of patients suffering from left ventricular disease. Surgeons implant this device as a treatment option for severe heart conditions such as heart failures, and chronic cardiac function disorders. The VAD mechanical pump has both internal and external components. The actual pump sits on or next to heart’s ventricle with a tube attached that routes the blood to aorta. A cable called driveline extends from the pump, out through the skin, and connects the pump to a controller and power sources worn outside the body. Ventricular assist devices are used in those patients who are suffering with class III and class IV advanced heart diseases as per New York Heart Association (NYHA) and patients who are awaiting for not suitable for heart transplantation.

Companies profiled:

  • Abiomed
  • Heart Ware International Inc.
  • St Jude Medical
  • Berlin Heart GmbH
  • Apaxis, Inc.
  • ReliantHeart
  • Sun Medical Technology Research
  • Terumo Corporation

Key Topics Covered:

  1. Scope of the report
  2. Executive summary
  3. Qualitative analysis
  4. Global VAD market, by type of indication, 2014 – 2022
  5. Global VAD market, by geography, 2014 – 2022
  6. Company profiles


Click below to access full report @


%d bloggers like this: